Moreover, increased levels of RPP40 are implicated in chemoresistance in acute myeloid leukemia [108] and an upregulated expression of RPP40 mRNA predicts recurrence in early-stage triple-negative breast cancer [109]. Here, RPP40 is linked to acute myeloid leukemia.